News Archives - Page 69 of 87

TuesdayNov 01, 2022 1:35 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Announces New Contracts, Indicative of Company’s Continued Reach

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced five new contracts. The contracts are with companies across the United States from several different industries. According to the announcement, the companies include an Ohio-based global pharmaceutical manufacturer and distributor of medical and laboratory products, as well as a provider of performance and data solutions for healthcare facilities; two hotels — one in Tennessee and one in Washington state; a sports complex in New York; and a multifamily housing complex in Pennsylvania. The contracts call for Knightscope ASRs to patrol and provide surveillance for everything from parking lots…

TuesdayNov 01, 2022 1:23 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures IRB Approval for Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of independent review board (“IRB”) approval for human clinical nicotine study NIC-H22-1, and that human dosing will begin soon. The 36-person human pharmacokinetic (“pk”) randomized, double blinded, cross-over study will be conducted in current cigarette smokers, wherein each person will visit the laboratory to be dosed three times over a period of weeks. Only one oral nicotine pouch (either DehydraTECH-nicotine; On! brand manufactured by Altria; or Zyn brand manufactured by Swedish Match) will be administered during each visit and evaluated. Predetermined questionnaires for subjective…

TuesdayNov 01, 2022 12:57 pm

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Exec to Present at Neuropsychiatric & Psychedelics Drug Development Summit

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be participating in the 5th annual Neuropsychiatric & Psychedelics Drug Development Summit. The summit runs through Nov. 2, 2022, and is being held in Boston. Cybin director of neuropharmacology Amy Reichelt, PhD, will present during the event; her presentation, titled “CYB004 — Modifications to DMT to Enhance its Therapeutic Potential,” includes an overview of the preclinical data for CYB004, Cybin’s deuterated dimethyltryptamine (DMT) program and the advantages of deuteration on its therapeutic effect. Reichelt’s presentation will begin at 1:15 p.m. ET today.“I am delighted to be…

MondayOct 31, 2022 10:17 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Shares Responses from Participants of Its Strikingly Different FIVE EV Crossover Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, is seeing an overwhelmingly positive response to its Strikingly Different FIVE EV Crossover tour. Tour participants, including potential buyers and Mullen investors, who reserve a spot on the tour are enjoying the opportunity to ride the Mullen EV Crossover and personally interact with Mullen’s updated infotainment system, which features PERSONA, Mullen’s proprietary Personal Vehicle Assistant technology. PERSONA uses the latest facial recognition technology, which enables the vehicle to provide a highly personalized experience to every driver of the Mullen FIVE. The tour kicked off in Pasadena, California, last week, and has…

FridayOct 28, 2022 12:39 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports Higher-than-Expected Preorders for Mullen FIVE Electric-SUV Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is accepting preorders for its Mullen FIVE vehicle, and the company’s Strikingly Different EV Crossover Tour has had a significant impact on those orders. The tour kicked off earlier this week, and preorders for the new SUV crossover quadrupled in the period leading up to and during the tour’s first stop in Pasadena, California. Those who attend the tour can take a test drive in the new EV, with a professional driver at the wheel; they also have an opportunity to interact with the vehicle’s innovative infotainment system and see…

ThursdayOct 27, 2022 1:22 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Successful Results of Human Clinical Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced that its human clinical study, HYPER-H21-4, may be the first-ever study to indicate a sustained drop in blood pressure (“BP”) in normally active hypertensive patients following multiple weeks of oral cannabidiol ("CBD") therapy. The study is evaluating Lexaria's patented DehydraTECH(TM)-CBD capsule formulation. LEXX reported that study results showed exceptional safety and tolerability and statistically significant lowering of 24-hour ambulatory BP as well as BP lowered for the duration of the entire five-week study. The study also indicated lowered BP for patients currently taking other antihypertensive drugs as well…

ThursdayOct 27, 2022 12:07 pm

TinyGemsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Enters $100M Agreement with Koito Manufacturing

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has signed a binding investment agreement with its long-term automotive tier 1 partner and current shareholder, Koito Manufacturing Co. Ltd. The company anticipates using the funds — $100 million — for its next stage of growth as it grows its lidar solutions and looks toward mass deployment. The agreement has been approved by Cepton’s board of directors and calls for Koito to purchase $100 million of convertible preferred stock. According to the announcement, the shares will be convertible, beginning on the first anniversary of the issue date, into…

ThursdayOct 27, 2022 11:35 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) EMBARK Program Graduates Class of Facilitators

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), and its EMBARK Psychedelic-Assisted Psychotherapy Training Program have announced the graduation of highly skilled facilitators who are now prepared to handle a range of experiences that participants of psychedelic-assisted psychotherapy may undergo. The training program includes foundational training enabling participants to learn the skills necessary to provide ethical care for and work with psychedelic-assisted psychotherapy patients. EMBARK is a leading-edge model of psychedelic-assisted psychotherapy that is implemented in Cybin’s phase 1/2a trial, which is designed to evaluate CYB003, Cybin’s investigational deuterated psilocybin analog. CYB003 has potential to…

ThursdayOct 27, 2022 10:56 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Featured in Latest Cleantech and Climate Change Podcast Report on EV Stocks

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is spotlighted in the new edition of the Cleantech and Climate Change Podcast, issued by Investorideas.com, a global news source and leading investor resource covering cleantech and renewable energy stocks. The episode focuses on the electric vehicle space and talks about the growth story of the EV market. During the episode, Mullen’s latest announcement that it has secured exclusive sales, distribution and branding rights to the new compact urban delivery electric vehicle, the I-GO(TM), was discussed. Fully EU Standard homologated and certified for sale in select European markets, the I-GO…

ThursdayOct 27, 2022 10:45 am

TinyGemsBreaks – Lottery.com (NASDAQ: LTRY) Names New Auditing Company

Lottery.com (NASDAQ: LTRY), a global technology company committed to deliver trusted gaming solutions whenever and wherever the lottery is played, has selected Yusufali & Associates LLC as its new independent registered public accounting firm. In that role, the company will perform quarterly financial reviews and annual audits for Lottery.com. In addition, the company has also announced the appointment of new independent board members, along with an interim CEO and interim CFO. Representatives of Yusufali and Associates noted that the firm is committed to the efficient and thorough review and audit of Lottery.com’s public filing in a timely manner. A U.S.-based partner-owned, public…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News